Previous research has found that aberrant Bcl-2 expression plays a key role in cardiomyocyte apoptosis and regulation of myocardial ischemia–reperfusion injury in MI/RI, given that its release rate significantly influences cardiomyocyte apoptosis and contractility [21,22]. This evidence concerns the gene BCL2 and myocardial infarction.